Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OKYO

OKYO Pharma Limited

May 11 • 10:44AM ET

1.67

+0.04 2.36 %

Healthcare • Biotechnology • United Kingdom • Micro • NASD

Peers: EYPT OCGN TNYA RVPH SPRO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.13	Insider Own	31.88%	Shs Outstand	38.45M	Perf Week	-0.68%
Market Cap	85.71M	Forward P/E	-	EPS next Y	-0.20	Insider Trans	0.00%	Shs Float	35.00M	Perf Month	10.50%
Enterprise Value	81.68M	PEG	-	EPS next Q	-	Inst Own	9.29%	Short Float	0.78%	Perf Quarter	-16.16%
Income	-4.61M	P/S	-	EPS this Y	16.67%	Inst Trans	-48.34%	Short Ratio	1.52	Perf Half Y	-36.56%
Sales	0.00M	P/B	-	EPS next Y	-100.00%	ROA	-123.47%	Short Interest	0.27M	Perf YTD	-19.40%
Book/sh	-0.09	P/C	20.31	EPS next 5Y	-	ROE	-	52W High	3.35 -50.18%	Perf Year	15.07%
Cash/sh	0.08	P/FCF	-	EPS past 3/5Y	-178.81% -114.91%	ROIC	-	52W Low	1.32 26.40%	Perf 3Y	11.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.56% 6.59%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1771.64%	Oper. Margin	-	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.58	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	53.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.58	EPS Q/Q	13.41%	SMA20	3.57%	Beta	-0.00	Target Price	7.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	2.93%	Rel Volume	0.10	Prev Close	1.63
Employees	-	LT Debt/Eq	-	Earnings	Dec 03	SMA200	-20.00%	Avg Volume	179.03K	Price	1.67
IPO	May 17, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	85.71% -	Trades		Volume	3,969	Change	2.36%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)